Glenmark Pharmaceuticals' US subsidiary has launched a generic eye itch treatment, Olopatadine Hydrochloride Ophthalmic Solution (OTC), addressing growing market demand.
New Delhi, Aug 19 (PTI) Glenmark Pharmaceuticals on Monday said its US-based subsidiary has introduced a generic medication used for eye itching.
Glenmark Therapeutics Inc, USA has launched Olopatadine Hydrochloride Ophthalmic Solution (OTC) in the US market, the Mumbai-based drug maker said in a regulatory filing.
Fabio Moreno, Head of OTC Sales & Marketing, Glenmark Pharmaceuticals Inc, said the launch of Olopatadine Ophthalmic Solution (USP, 0.1 per cent), addresses a growing demand for a new supplier in this category.
"This addition highlights our commitment to meeting market needs and providing high-quality over-the-counter solutions for our customers," Moreno said.
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback